The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom

Transplant International

Volumn 20, Issue 4, 2007, Pages 331-337

  Young, Alastair L ^a   Rajagenashan, Rajasundurum ^a   Asthana, Sonal ^a   Peters, Christopher J ^a   Toogood, Giles J ^a   Davies, Mervyn H ^a   Lodge, J Peter A ^a   Pollard, Stephen G ^a   Rajendra Prasad, K ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Allocation; Intention to treat; Liver; MELD; Outcome

Indexed keywords

SODIUM;

ADULT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPONATREMIA; LIVER DISEASE; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIODICITY; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME; UNITED KINGDOM;

BILIRUBIN; CREATININE; FEMALE; GREAT BRITAIN; HUMANS; LIVER TRANSPLANTATION; MALE; PREDICTIVE VALUE OF TESTS; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SODIUM; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTS; WAITING LISTS;

EID: 33847204320     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00441.x     Document Type: Article

References (29)

1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PL. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
2. Kamath PS, Wiesener RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
3. Wiesner RH, Edwards EB, Kamath PS et al. Mayo end-stage liver disease model (MELD) score predicts liver transplant waiting list mortality: Implications for liver allocation policy (abstract). Transplantation 2001; 71(Suppl.1): 461.
4. Neuberger J, James O. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet 1999; 354: 1636.
5. UK Transplant. Available at http://www.uktransplant.org.uk (accessed on April 2006).
6. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld S. Survival after liver transplantation in the United States: a disease specific analysis of the UNOS database. Liver Transpl 2004; 10: 886.
7. Desai NM, Mange KC, Crawford MD et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004; 77: 99.
8. Saab S, Wang V, Ibrahim AB et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003; 9: 473.
9. Jacob M, Copley LP, Lewsey JD et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004; 10: 903.
10. Onaca NN, Levy MF, Sanchez EQ et al. A correlation between pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9: 117.
11. Habib S, Berk B, Chang CCH et al. MELD and prediction of post liver transplant survival. Liver Transpl 2006; 12: 440.
12. Freeman RB. Liver allocation: the intent-to-treat approach. Transpl Int 2006; 19: 270.
13. Heuman DM, Abou-assi SG, Habib A et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk of early death. Hepatology 2004; 40: 802.
14. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336.
15. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41: 32.
16. Freeman RB, Wiesener RH, Edwards E, Harper A, Merrion R, Wolfe R. Results of the first year of the new allocation plan. Liver Transpl 2004; 10: 7.
17. Kanwal F, Dulai GS, Spiegel BMR, Yee HF, Gralnek IM. A comparison of liver transplant outcomes in the pre- vs post-MELD era. Aliment Pharmacol Ther 2005; 21: 169.
18. Jacob M, Copley LP, Lewsy JD et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004; 10: 903.
19. Porcel A, Diaz F, Rendon P, Marcias M, Martin-Herrera L, Giron-Gonzalez JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Int Med 2002; 162: 323.
20. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003; 38: S69.
21. Gines A, Escorsell A, Gines P et al. Incidence, predictive factors and prognosis of hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229.
22. Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol 2001; 8: 103.
23. Bambha K, Kim WR, Kremers WK et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD scores. Am J Transplant 2004; 4: 1798.
24. Northup PG, Berg CL. Preoperative delta-MELD score does not independently predict mortality after liver transplantation. Am J Transplant 2004; 4: 1643.
25. Wiesener RH. Patient selection in the era of donor liver shortage: current US policy. Nat Clin Pracr Gastroenterol Hepatol 2005; 2: 24.
26. Amin MG, Wolf MP, Tenbrook JA et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004; 10: 1468.
27. Merrion RM, Schaubel DE, Dykstra DM, Freeman RB, Port KF, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307.
28. Barshes NR, Rojo J, Nguyen TS et al. How do Donor and Patient Characteristics interact in influencing posttransplant patient survival. Am J Transplant 2006; 6: 95.
29. Saab S, Ibrahim AB, Shpaner A et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 2005; 11: 218.